About Us

We are a UK-based spinout company capitalising on our academic founder’s world-leading gene therapeutic translational research at the University of Sheffield.

Our journey began in November 2023, and since then, we have been unwavering in our efforts to turn innovative gene therapies into tangible solutions that could change the lives of young children worldwide.

Our People

Professor Mimoun Azzouz

Professor Mimoun Azzouz

Academic Founder, Chief Scientific Officer and Chair of Advisory Board. Chair of Translational Neuroscience at the University of Sheffield. Director of Gene Therapy Innovation & Manufacturing Centre (GTIMC). Former Director of Neurobiology at Oxford Biomedica.

Peter Nolan

Peter Nolan

Founder, Chair and Interim CEO. Former Director, Chief Business Officer and key executive of Oxford Biomedica since its inception. Over 25 years of experience in gene therapy commercialisation, leading negotiations on critical deals such as Novartis and Sanofi.

Chris Edwards

Chris Edwards

Founder and Chief Business Officer. Seasoned entrepreneur with 20 years of experience founding new ventures.